News

Hypertension in Pregnancy and Postpartum: Expanding Education and Prevention Efforts to Save Lives

HDPs, including preeclampsia, superimposed preeclampsia, chronic hypertension, gestational hypertension, Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, and eclampsia, are the leading cause of maternal and infant illness and death in the United States. Continue Reading

More Than 130 Organizations Express Concern Over Changes to CDC’s Advisory Committee on Immunization

The 130+ undersigned medical, nursing, public health, and patient advocacy groups express our deep concern about the revised charter for the Advisory Committee on Immunization Practices (ACIP) published on April 9. Continue Reading

Novel AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery, New Research Shows

A novel artificial intelligence (AI) model accurately detected the presence of placenta accreta spectrum (PAS), a dangerous pregnancy condition that often goes undetected with current screening methods, according to new research presented today at the SMFM 2026 Pregnancy Meeting. Continue Reading

New Study: Routine Aspirin Therapy Prevents Severe Preeclampsia in At-Risk Populations

Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™.   Continue Reading

Study: Discontinuing Antidepressants in Pregnancy Nearly Doubles Risk of Mental Health Emergencies

Pregnant patients who stopped taking their antidepressant medication during pregnancy were almost twice as likely to experience a mental health emergency compared with pregnant patients who continued taking their prescription, according to new research presented today at the SMFM Pregnancy Meeting. Continue Reading

SMFM Announces New Board Members

The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading

SMFM Issues New Guidance on Diagnosing and Managing Heart Failure During Pregnancy and Postpartum

Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading

SMFM and SOGH Announce Strategic Partnership to Strengthen Hospital-Based Obstetric Care

The Society for Maternal-Fetal Medicine (SMFM) and the Society of OB/GYN Hospitalists (SOGH) are pleased to announce a focused commitment to our partnership that prioritizes the advancement of hospital-based obstetric care across the United States. Continue Reading

Getting the Facts Straight: Pregnancy, Depression, and SSRIs

By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading

Why Federally Funded Research Is Important to Maternal-Fetal Medicine

By Kristen A. Cagino, MD As physicians, we recognize that medical practice is built on a foundation of research. Discovering new therapies, navigating a global pandemic, and identifying the safest, evidence-based management strategy for complex conditions all rely on rigorous, well-designed... Continue Reading

The Rise of Measles is Entirely Preventable

By Brenna L. Hughes, MD, MSc, and Naima T. Joseph, MD In late February 2025, the first confirmed measles-related death in the United States in a decade was reported when an unvaccinated school-aged child in West Texas died. A second measles-related death of a child in Texas is under... Continue Reading

Large Study Finds Maternal Biomarker Test Reduces Neonatal Morbidities and Improves Outcomes

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 One of the Largest Studies on Preterm Birth Finds a Maternal Biomarker Test Significantly Reduces Neonatal Morbidities and Improves Neonatal Outcomes Denver, Colo. ― Preterm birth ― defined as delivery before the 37th week of... Continue Reading